US Bancorp’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $88.8M | Sell |
3,685,691
-178,203
| -5% | -$4.66M | 0.1% | 146 |
|
|
2026
Q1 | $108M | Sell |
3,863,894
-124,643
| -3% | -$3.32M | 0.13% | 123 |
|
|
2025
Q4 | $99.3M | Sell |
3,988,537
-270,825
| -6% | -$6.83M | 0.12% | 136 |
|
|
2025
Q3 | $109M | Sell |
4,259,362
-461,942
| -10% | -$11.4M | 0.13% | 128 |
|
|
2025
Q2 | $114M | Sell |
4,721,304
-491,946
| -9% | -$11.5M | 0.14% | 119 |
|
|
2025
Q1 | $132M | Sell |
5,213,250
-563,335
| -10% | -$14.7M | 0.18% | 104 |
|
|
2024
Q4 | $153M | Sell |
5,776,585
-491,587
| -8% | -$13.3M | 0.2% | 95 |
|
|
2024
Q3 | $181M | Sell |
6,268,172
-257,458
| -4% | -$7.51M | 0.23% | 81 |
|
|
2024
Q2 | $183M | Sell |
6,525,630
-145,351
| -2% | -$4M | 0.25% | 78 |
|
|
2024
Q1 | $185M | Sell |
6,670,981
-486,674
| -7% | -$13.5M | 0.26% | 75 |
|
|
2023
Q4 | $206M | Sell |
7,157,655
-612,986
| -8% | -$18.5M | 0.3% | 68 |
|
|
2023
Q3 | $258M | Sell |
7,770,641
-188,422
| -2% | -$6.66M | 0.42% | 50 |
|
|
2023
Q2 | $292M | Sell |
7,959,063
-189,273
| -2% | -$7.37M | 0.47% | 46 |
|
|
2023
Q1 | $332M | Sell |
8,148,336
-183,545
| -2% | -$7.93M | 0.56% | 41 |
|
|
2022
Q4 | $427M | Buy |
8,331,881
+831,556
| +11% | +$39.9M | 0.76% | 31 |
|
|
2022
Q3 | $328M | Sell |
7,500,325
-169,442
| -2% | -$8.23M | 0.68% | 35 |
|
|
2022
Q2 | $402M | Sell |
7,669,767
-102,960
| -1% | -$5.25M | 0.78% | 26 |
|
|
2022
Q1 | $402M | Sell |
7,772,727
-245,805
| -3% | -$12.8M | 0.67% | 32 |
|
|
2021
Q4 | $473M | Buy |
8,018,532
+35,782
| +0.4% | +$1.77M | 0.75% | 30 |
|
|
2021
Q3 | $343M | Sell |
7,982,750
-5,636
| -0.1% | -$250K | 0.65% | 34 |
|
|
2021
Q2 | $313M | Buy |
7,988,386
+37,570
| +0.5% | +$1.46M | 0.59% | 39 |
|
|
2021
Q1 | $288M | Buy |
7,950,816
+158,052
| +2% | +$5.61M | 0.58% | 38 |
|
|
2020
Q4 | $287M | Sell |
7,792,764
-228,491
| -3% | -$8.38M | 0.62% | 37 |
|
|
2020
Q3 | $279M | Buy |
8,021,255
+302,732
| +4% | +$10.6M | 0.68% | 32 |
|
|
2020
Q2 | $239M | Buy |
7,718,523
+339,204
| +5% | +$11.5M | 0.63% | 36 |
|
|
2020
Q1 | $229M | Sell |
7,379,319
-237,486
| -3% | -$8.09M | 0.71% | 31 |
|
|
2019
Q4 | $283M | Sell |
7,616,805
-136,957
| -2% | -$4.88M | 0.72% | 30 |
|
|
2019
Q3 | $264M | Sell |
7,753,762
-312,287
| -4% | -$11.4M | 0.72% | 29 |
|
|
2019
Q2 | $332M | Sell |
8,066,049
-89,303
| -1% | -$3.55M | 0.92% | 22 |
|
|
2019
Q1 | $329M | Sell |
8,155,352
-152,583
| -2% | -$6.11M | 0.95% | 19 |
|
|
2018
Q4 | $344M | Sell |
8,307,935
-147,942
| -2% | -$6.14M | 1.11% | 17 |
|
|
2018
Q3 | $354M | Sell |
8,455,877
-143,293
| -2% | -$5.52M | 1.02% | 18 |
|
|
2018
Q2 | $296M | Sell |
8,599,170
-273,495
| -3% | -$9.35M | 0.91% | 20 |
|
|
2018
Q1 | $299M | Sell |
8,872,665
-175,298
| -2% | -$6.03M | 0.92% | 18 |
|
|
2017
Q4 | $311M | Sell |
9,047,963
-244,413
| -3% | -$8.33M | 0.95% | 17 |
|
|
2017
Q3 | $315M | Buy |
9,292,376
+45,750
| +0.5% | +$1.47M | 1.01% | 16 |
|
|
2017
Q2 | $295M | Sell |
9,246,626
-111,251
| -1% | -$3.51M | 0.98% | 18 |
|
|
2017
Q1 | $304M | Sell |
9,357,877
-53,668
| -0.6% | -$1.69M | 1.04% | 15 |
|
|
2016
Q4 | $290M | Sell |
9,411,545
-314,886
| -3% | -$9.61M | 1.04% | 16 |
|
|
2016
Q3 | $313M | Sell |
9,726,431
-138,689
| -1% | -$4.64M | 1.16% | 13 |
|
|
2016
Q2 | $330M | Sell |
9,865,120
-23,722
| -0.2% | -$757K | 1.25% | 12 |
|
|
2016
Q1 | $278M | Sell |
9,888,842
-286,204
| -3% | -$8.18M | 1.09% | 14 |
|
|
2015
Q4 | $312M | Sell |
10,175,046
-339,223
| -3% | -$10.7M | 1.25% | 14 |
|
|
2015
Q3 | $313M | Sell |
10,514,269
-214,781
| -2% | -$6.89M | 1.31% | 10 |
|
|
2015
Q2 | $341M | Sell |
10,729,050
-198,931
| -2% | -$6.48M | 1.32% | 11 |
|
|
2015
Q1 | $361M | Sell |
10,927,981
-28,954
| -0.3% | -$921K | 1.39% | 10 |
|
|
2014
Q4 | $324M | Sell |
10,956,935
-53,884
| -0.5% | -$1.55M | 1.25% | 12 |
|
|
2014
Q3 | $309M | Sell |
11,010,819
-71,712
| -0.6% | -$2.01M | 1.25% | 13 |
|
|
2014
Q2 | $312M | Sell |
11,082,531
-209,789
| -2% | -$5.98M | 1.24% | 15 |
|
|
2014
Q1 | $344M | Sell |
11,292,320
-155,118
| -1% | -$4.62M | 1.41% | 11 |
|
|
2013
Q4 | $333M | Sell |
11,447,438
-188,100
| -2% | -$5.47M | 1.35% | 14 |
|
|
2013
Q3 | $317M | Sell |
11,635,538
-244,610
| -2% | -$6.66M | 1.4% | 13 |
|
|
2013
Q2 | $316M | Buy |
+11,880,148
| New | +$328M | 1.44% | 12 |
|
Other funds holding PFE
US Bancorp's PFE Position: Q2 2026 in Review
US Bancorp reduced its Pfizer (PFE) stake by 4.6% in Q2 2026, selling an estimated $4.66M and leaving 3,685,691 shares worth $88.8M. The position accounts for 0.1% of the portfolio, ranked #146.
US Bancorp first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $473M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- US Bancorp held 3,685,691 shares of Pfizer worth $88.8M as of Q2 2026.
- US Bancorp sold 178,203 Pfizer shares in Q2 2026, an estimated $4.66M.
- Pfizer made up 0.1% of US Bancorp's portfolio in Q2 2026, its #146 holding.
- US Bancorp first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- US Bancorp's Pfizer position peaked at $473M in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.